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Abstract
Background: Genetic interference by DNA, mRNA or morpholino injection is a widely used
approach to study gene function in developmental biology. However, the lack of temporal control
over the activity of interfering molecules often hampers investigation of gene function required
during later stages of embryogenesis. To elucidate the roles of genes during embryogenesis a
precise temporal control of transgene expression levels in the developing organism is on demand.
Results: We have generated a transgenic Gal4/Vp16 activator line that is heat-shock inducible,
thereby providing a tool to drive the expression of specific effector genes via Gal4/Vp16. Merging
the Gal4/Vp16-UAS system with the I-SceI meganuclease and the Sleeping Beauty transposon system
allows inducible gene expression in an entirely uniform manner without the need to generate
transgenic effector lines. Combination of this system with fluorescent protein reporters
furthermore facilitates the direct visualization of transgene expressing cells in live embryos.
Conclusion: The combinatorial properties of this expression system provide a powerful tool for
the analysis of gene function during embryonic and larval development in fish by ectopic expression
of gene products.
Background
The most widely used strategies to investigate the function
of genes in medaka (Oryzias latipes) are the analyses of
mutants, miss-expression of wild type genes or their vari-
ants by mRNA injection and gene specific translational
inhibition by morpholino injections [1-3]. However, the
phenotype of a given mutation mainly reflects the first
temporal function of the affected gene in embryonic
development, obscuring possible later functions. Simi-
larly, mRNA and morpholinos exert their functions
immediately following injection, providing information
only on the early role of the gene of interest. A detailed
analysis of gene function in a given process can thus be a
difficult task. The Gal4/UAS system provides an alterna-
tive and more specific strategy to analyze specific func-
tions of a gene [4,5]. The direct application of the
Drosophila Gal4-UAS approach, by the generation of trans-
genic lines, has been established successfully in zebrafish
[6,7]. However, the generation of different transgenic acti-
vator and effector lines may be a time- and space-consum-
ing task, and expression levels in these transgenic lines are
weak, probably due to a limited transactivation potential
of Gal4 in fish. Gal4/Vp16, a fusion of the yeast Gal4
DNA-binding domain with the strong Vp16 transactiva-
tion domain of the herpes simplex virus [8] can be used to
enhance transactivation efficacy. Yet, strong transcrip-
tional activators can cause unspecific promoter squelch-
ing [9] resulting in retardation of embryogenesis [10].
Published: 26 October 2004
BMC Biotechnology 2004, 4:26 doi:10.1186/1472-6750-4-26
Received: 20 July 2004
Accepted: 26 October 2004
This article is available from: http://www.biomedcentral.com/1472-6750/4/26
© 2004 Grabher and Wittbrodt; licensee BioMed Central Ltd. 
This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Biotechnology 2004, 4:26 http://www.biomedcentral.com/1472-6750/4/26
Page 2 of 6
(page number not for citation purposes)
Nonetheless, the Gal4/Vp16-UAS system has been used in
zebrafish in transient approaches resulting in mosaic, but
easily detectable transgene expression [11].
We have applied the Gal4/Vp16-UAS system for transient
transactivation in a heat-shock inducible transgenic Gal4/
Vp16 activator line. Generation of transgenic medaka
lines, which allow the induction of the Gal4/Vp16 activa-
tor to 'physiological' (i.e. non-toxic) levels was achieved
by using a 5' truncated version of the zebrafish heat-shock
promoter HSP70 [12]. Using a heat-shock promoter to
drive expression of the Gal4/Vp16 activator allows tight
temporal control of activator and effector (reporter) gene
expression. To trace transgene expression in cells of living
embryos we have used the cyan fluorescent and yellow
fluorescent proteins (CFP, YFP). Combination with the
meganuclease (MN) transgenesis system [13] and the
direct-inverted repeats (IR/DR) of the Sleeping Beauty (SB)
transposon system [14] yielded high numbers of trans-
gene expressing cells. Thus, in contrast to the entirely
mosaic nature of a transient approach reported thus far,
the combined use of a transgenic activator line with sys-
tems enhancing even DNA distribution or early integra-
tion allows uniform expression of injected effector genes
upon induction by heat-shock treatment without an
immediate need to generate transgenic UAS lines.
Results and discussion
Generation of a heat-shock inducible transgenic Gal4/
Vp16 activator line (pCG6.0WCS/T)
DNA injection leading to mosaic expression in G0 allows
in vivo tracing of transgene-expressing cells and observa-
tion of effects exerted by the transgene through applica-
tion of fluorescent markers [11]. However, elucidation of
biological questions sometimes requires ubiquitous
expression of transgenes in a temporally controlled man-
ner. While the MN protocol strongly reduces mosaicism,
it does so only in a fraction of injected embryos ([13], Fig.
1F,1G,1H,1I,1J,1K and Table 1). This can be improved by
the use of transgenic animals providing inducible and suf-
ficient expression in all cells.
The idea is to combine stable heat-shock inducible expres-
sion of the Gal4/Vp16 activator with transient expression
of effector genes upon microinjection. The effector con-
structs are uniformly distributed in the entire embryo due
to the presence of the SB direct-inverted repeats [15]. We
have designed two activator/reporter vectors containing
Gal4/Vp16 under control of a 1.5 kb fragment of the
zebrafish (zf) HSP70 promoter (pCG5.0WCS) or a 0.6 kb
5' truncated fragment of zfHSP70, respectively
(pCG6.0WCS). Both vectors contain CFP downstream of
several UAS elements as an internal reporter. The IR/DRs
of SB and two I-SceI meganuclease sites flank this entire
expression cassette (Fig. 1A). The internal reporter pro-
vides a direct read-out for activator expression. A third vec-
tor (pCG3.0Y), containing YFP downstream of several
UAS elements and flanked by IR/DRs, was designed as an
independent reporter (Fig. 1A).
It has been shown that the Gal4/Vp16 activator can inter-
fere with general transcription by titrating the basal tran-
scription machinery [16]. We observed developmental
retardation and malformation in all embryos injected
with Gal4/Vp16 driven by ubiquitous promoters. Simi-
larly, co-injection of high concentrations of Gal4/Vp16
mRNA (50 ng/µl) with pCG5.0WCS always resulted in
developmental malformations (not shown). However,
DNA co-injections did not affect embryonic development
in transient experiments when the HSP70 promoter was
used to control Gal4/Vp16 expression (Fig.
1B,1B',1F,1G,1H,1I,1J,1K). Moreover, co-injections of
low concentrations of Gal4/Vp16 mRNA (3.5 ng/µl) with
the activator/reporter construct pCG5.0WCS also showed
no effects on embryogenesis (Fig. 1C,1C'), suggesting that
the toxicity of the activator depends on the expression
level.
The truncated version of the zfHSP70 promoter fragment
used in the activator/reporter construct pCG6.0WCS
showed a moderate activation upon heat-shock treat-
ment. This allowed adjusting the induction levels by vary-
ing the heat-shock duration. A transgenic medaka line was
established (by co-injection of circular vector
pCG6.0WCS with MN) in which expression levels directly
correlated with the heat-shock duration. Extended heat-
shocks resulted in very high expression levels, but also
caused retardation phenotypes due to the strong transac-
tivation potential of the Gal4/Vp16 fusion protein. Com-
parable phenotypes were not observed in heat-shock
treated wild type embryos. Depending on the develop-
mental stage at the time of induction, the duration of
heat-shock treatment was adjusted to induce Gal4/Vp16
and reporter expression without interfering with embry-
onic development. Induction periods ranged from one
minute of heat-shock at 37°C at early stages (~st16/
21hpf) to 10 minutes at later stages (~st22/38hpf). On
top of uniform CFP expression in the entire embryo and
yolk upon heat-shock, some regions of the embryo
showed additional responsiveness of the reporter (Fig.
1E,1E').
Microinjection experiments and RT-PCR revealed that
reporter gene (CFP) expression in transgenic fish is medi-
ated by Gal4/Vp16. Offspring of pCG6.0-WCS/T trans-
genic fish was injected with Gal4/Vp16 mRNA (3.5 ng/µl)
at the one-cell stage without heat-shock treatment.
Injected embryos exhibited uniform expression of CFP
shortly after the onset of zygotic transcription at the mid-BMC Biotechnology 2004, 4:26 http://www.biomedcentral.com/1472-6750/4/26
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blastula transition [17], indicating that CFP expression
was induced in response to Gal4/Vp16 (Fig. 1D,1D').
Schematic representation of Gal4/Vp16-UAS expression vectors (A), comparison of induction levels between transient and  transgenic approaches (B-E') and transient Gal4/Vp16 mediated reporter expression in medaka embryos induced by heat-shock  (F-K) Figure 1
Schematic representation of Gal4/Vp16-UAS expression vectors (A), comparison of induction levels between 
transient and transgenic approaches (B-E') and transient Gal4/Vp16 mediated reporter expression in medaka 
embryos induced by heat-shock (F-K). A; Gal4/Vp16 activator units driven by a 1.5 kb (pCG5.0WCS) or a 600 bp 
(pCG6.0WCS) heat-shock promoter fragment followed by a SV40 polyadenylation signal are shown on the left. Reporter units 
are separated from the activator units by the pBSII backbone. YFP (pCG3.0Y) or CFP (pCG5.0WCS/6.0WCS) open reading 
frames are placed downstream of 4 UAS elements and followed by a SV40 polyadenylation signal. Entire expression cassettes 
are flanked by the IR/DRs of the SB transposon system. Additionally, I-SceI meganuclease sites flank the expression cassettes of 
activator vectors. Abbreviations and actual sizes of each vector are given. B-E'; Wild type medaka embryos were injected with 
pCG5.0WCS and MN and subjected to heat-shock treatment (B, B') or with MN and Gal4/Vp16 mRNA without treatment (C, 
C'). Similarly, the transgenic activator line pCG6.0WCS/T was injected with Gal4/Vp16 mRNA (D, D') or subjected to heat-
shock treatment (E, E'). Anterior is to the top (B-E'). DNA and RNA concentrations are indicated together with the develop-
mental stage and the duration of heat-shock treatment. Microinjection of the activator/reporter plasmid pCG5.0WCS results 
in activation of CFP according to the distribution of plasmid DNA (B-C'). In contrast, induction of activator and reporter in the 
transgenic line by mRNA injection or heat-shock treatment results in ubiquitous and entirely uniform expression of CFP (D-E'). 
F-K: Activator and reporter vectors were injected into one-cell stage medaka embryos. Anterior is to the left (F-K). Develop-
mental stage at heat-shock induction and duration of treatment is indicated. HS treatment of up to 2 hours did not interfere 
with embryonic development but yielded detectable transgene expression (F-K). CFP (internal reporter) shows the expression 
pattern of the activator Gal4/Vp16. YFP shows activation of the independent reporter. Co-injection of activator pCG5.0WCS 
and independent reporter pCG3.0Y (100 ng/µl each) resulted in mosaic activation of reporter gene expression (F-H) only. Co-
injection of activator pCG5.0WCS (5 ng/µl) and independent reporter pCG3.0Y (100 ng/µl) with I-SceI resulted in a broad 
range of different levels of mosaicism. Notably, 16% of co-injected embryos showed highly uniform expression (I-K). Abbrevia-
tions: CFP, cyan fluorescent protein; HS, heat-shock; hpf, hours post fertilization; IR/DR, inverted/direct repeats; MN, meganu-
clease; pA, SV40 polyadenylation signal; pBS, pBluescriptII; st, developmental stage; UAS, upstream activating sequence; zf, 
zebrafish.BMC Biotechnology 2004, 4:26 http://www.biomedcentral.com/1472-6750/4/26
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We applied RT-PCR for the dose/response analysis of acti-
vator and reporter mRNA (Fig. 2A). Transcripts of Gal4/
Vp16 were detectable already 10 minutes after a heat-
shock of 90 seconds at 37°C. Following a steady increase
Table 1: Microinjection of reporter vector.
Reporter expression






+ wildtype 74 52 61/61 (82%) 12/12 (16%)
pCG3.0Y - pCG6.0WCS/T3 162 29 -/- 73/73 (100%)
1...Leaky expression was mainly observed in the yolk only
2...Expression of internal (CFP) and independent (YFP) effector in the embryonic body was scored separately; CFP/YFP
3...Injection was performed in offspring of heterozygous carriers mated to wildtype fish, resulting in ~50% transgenic embryos
Kinetics of activator and reporter induction (A) and activation of an independent reporter in pCG6.0WCS/T (B-J) Figure 2
Kinetics of activator and reporter induction (A) and activation of an independent reporter in pCG6.0WCS/T 
(B-J). A; Transcriptional induction of the activator Gal4/Vp16 and the internal reporter (CFP) in pCG6.0WCS/T was analyzed 
by RT-PCR. Embryos were heat-shock for 90 seconds at st20/31.5hpf and were allowed to recover for the indicated periods of 
time. Activator transcripts were detectable already 10 minutes after induction and the levels increased up to 3 hours. Degrada-
tion to undetectable levels was complete after 20 hours. Activator dependent transcription of the internal reporter CFP was 
observed only after 2 hours and levels were still increasing after 25 hours. C-actin was used as an internal control. (B-J); The 
independent reporter plasmid pCG3.0Y was injected into the transgenic Gal4/Vp16 activator line. Anterior is to the left (B-J). 
Expressions of both internal and independent reporters were observed in a weak to strong ubiquitous manner (B-J). Occa-
sional higher levels of internal reporter expression were observed in some parts of the embryonic body. These higher levels 
were paralleled by independent reporter expression (B-D, H-J). Mosaic clones exerting stronger YFP expression reflect locally 
higher plasmid concentrations (B-J). Abbreviations: h, hours; hpf, hours post fertilization; HS, heat-shock; M, size marker; st, 
developmental stage.BMC Biotechnology 2004, 4:26 http://www.biomedcentral.com/1472-6750/4/26
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until about three hours after induction, Gal4/Vp16 mes-
sages were degraded between five and ten hours to unde-
tectable levels after twenty hours. CFP mRNA was first
detected after two hours and transcript levels were still
increasing after 25 h. This indicates that the transcription
of the reporter CFP is controlled by Gal4/Vp16 protein
and that active Gal4/Vp16 is still present when the
amount of its transcripts already dropped below detecta-
ble levels (Fig. 2A).
Activation of an independent reporter upon injection into 
the transgenic activator line pCG6.0WCS/T
We tested the Gal4/Vp16 activator line pCG6.0WCS/T as
a tool to induce expression of an independent reporter
upon injection of plasmid DNA (pCG3.0Y). Transgenic
embryos were injected with different concentrations of
the reporter pCG3.0Y (5–150 ng/µl). Injected embryos
were subjected to heat-shock treatment at different devel-
opmental stages for various periods of time, kept at 28°C
thereafter and monitored for activator and effector expres-
sion during the following days. Due to the SB IR/DRs
flanking the expression cassette, the independent reporter
was distributed equally in the entire embryo resulting in
ubiquitous expression of YFP, entirely co-localizing with
the internal reporter (CFP). Additional mosaic clones of
cells expressing YFP at higher levels presumably reflect
higher plasmid concentrations in these cells (Fig.
2B,2C,2D,2E,2F,2G,2H,2I,2J and Table 1). However, YFP
expression levels appeared relatively independent from
the DNA concentration, but were directly correlated to the
expression levels of the activator or internal reporter,
respectively.
Conclusions
Here we show that the Gal4/Vp16-UAS transactivation
system can be efficiently used in medaka. By using fluores-
cent proteins as internal or independent reporter, cells co-
expressing the activator and the gene of interest can be vis-
ualized directly. Transparency of these fish embryos
allows the evaluation of the cellular fate and response to
ectopically expressed genes by time-lapse analyses. The
combination with inducible promoters permits temporal
control of effector gene expression and enables the mod-
ulation of the response intensity by adjusting the duration
of the heat-shock treatment. This inducible system can be
used in transient experiments to study the behavior of
transgene expressing cells in an otherwise wild type envi-
ronment. The combination with the MN and SB system
offers to tailor a range of different levels of mosaicism
(Fig. 1F,1G,1H,1I,1J,1K). A transgenic Gal4/Vp16 activa-
tor line was generated, which provides a powerful tool to
induce activator and effector gene expression in a ubiqui-
tous manner at a given time-point (Fig. 1E,1E'). When
used in microinjection approaches of reporter vectors
containing IR/DRs, our transgenic activator line allows
ubiquitous and uniform expression of the reporter gene
without the need to generate transgenic effector (UAS)
lines (Fig. 2B,2C,2D,2E,2F,2G,2H,2I,2J). In addition to
temporal control mediated by the heat-shock promoter,
induction using a focused laser-beam [12] could provide




A YFP/SV40pA cassette was cloned downstream of a
4xUAS/dHSP70 element (non responsive to heat-shock;
kind gift of M. Gonzalez-Gaitan). This entire cassette was
cloned into pCG1.1 containing the IR/DR sequences of
the SB transposable element [14] resulting in a 5.1 kb
plasmid containing the reporter cassette (4xUAS/
dHSP70/YFP/SV40pA) and the pBSII backbone flanked
by a left and right IR/DR of SB (Fig. 1).
pCG5.0WCS
A 1.5 kb zebrafish HSP70 promoter fragment [12] was
subcloned upstream of Gal4/Vp16/SV40pA. The entire
cassette was further subcloned into pCG3.0C (containing
CFP instead of YFP, see above) resulting in a 8.7 kb plas-
mid (pCG5.0C) containing the expression cassettes
zfHSP70/Gal4/Vp16/SV40pA followed by 4xUAS/CFP/
SV40pA flanked by the IR/DRs of SB. Finally, the expres-
sion cassettes including the inverted repeats were cloned
into a I-SceI backbone vector [13] and verified by sequenc-
ing (Fig. 1).
pCG6.0WCS
The 1.5 kb zfHSP70 promoter fragment in pCG5.0WCS
was replaced by a truncated zfHSP70 promoter fragment
lacking 900 bp 5' to the internal BamHI site resulting in a
7.8 kb plasmid that was verified by sequencing (Fig. 1).
Further structural details of the activator and reporter vec-
tors are available upon request.
pCGGal4/Vp16
A Gal4/Vp16 fusion construct (Gal4 DNA binding
domain: amino acids (aa) 1–147 and Vp16 transactiva-
tion domain: aa 411–491) was designed from Clontech
vectors pM (Gal4) and pM3-VP16 (Vp16) and cloned into
pCS2+ [18].
Gal4/Vp16 mRNA was transcribed in vitro from pCGGal4/
Vp16 using the mMessage mMachine kit (Ambion Inc.).
Microinjection and heat-shock treatment of medaka 
embryos
For microinjections, one-cell stage embryos of the Cab
inbred strain were used. Microinjection capillaries were
backfilled with the injection solution [DNA (5–150 ng/
µl); Yamamoto buffer (1×) or DNA (5 ng/µl); YamamotoBMC Biotechnology 2004, 4:26 http://www.biomedcentral.com/1472-6750/4/26
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buffer (0.5×); I-SceI buffer (0.5×, New England Biolabs);
I-SceI meganuclease (0.35 u/µl, New England Biolabs)
with or without Gal4/Vp16 mRNA (3.5–50 ng/µl)]. DNA
was prepared using a Qiagen Maxiprep kit (Qiagen, USA)
and dialyzed using nitrocellulose filters (#VSW01300;
Millipore, USA). DNA was injected through the chorion
into the cytoplasm of one-cell stage embryos. Heat-shock
treatment was performed in small volumes (100–200 µl)
using a waterbath at 37°C. Animals used in the study were
kept according to national and international ethical pro-
visions for animal husbandry as implemented at EMBL.
Microscopy
Embryos were observed and scored using a MZFLIII dis-
secting microscope with a 436/20 nm (EF); 480/40 nm
(BF) filter set for CFP, a 510/20 nm (EF); 560/40 nm (BF)
filter set for YFP and a 360/40 nm (EF); 420 nm (BF) filter
set for UV/Brightfield. The stereomicroscope was
equipped with a DC500 digital camera for imaging (Leica
Microsystems, Germany).
RNA isolation and RT-PCR
Transgenic embryos were heat-shocked and subsequently
kept at 28°C to recover for different periods of time. Total
RNA was isolated from individual embryos as described
[19]. Total RNA was subjected to reverse transcription
(SuperscriptII, Gibco-BRL) using a mixture of random
hexamer primers (25 µM, Amersham) and gene specific
oligomeres for Gal4/Vp16 (25 µM; 5'-CCACGTC-
CAAAGCCCCATAC-3') and CFP (25 µM; 5'-GTTCATC-
CATGCCATGTGTAATCCC-3') in a 20 µl reaction. 2 µl of
each RT reaction was used for PCR in a 50 µl reaction. The
primer pairs used were Gal4/Vp16up2 (5'-GATAATGT-
GAATAAAGATGCCGTCA-3') and Gal4/Vp16low2 (5'-
CCACGTCCAAAGCCCCATAC-3') to amplify a 420 bp
fragment, and CFPup2 (5'-TCAAGGAGGACGGCAA-
CATC-3') and CFPlow2 (5'-GTTCATCCATGCCATGTG-
TAATCCC-3') to amplify a 320 bp fragment.
Amplification of a 580 bp fragment of c-actin was used as
an internal control using the intron-spanning primer pair
c-actinup2 (5'-GCCGCGACCTTACAGACTACCT-3') and
c-actinlow2 (5'-CTGTTTAGAAGCATTTGCGGTGGAC-3').
An initial 1 min. denaturation step at 95°C was followed
by an additional denaturation step for 30 sec. at 95°C,
annealing for 30 sec. at 60°C and elongation at 72°C for
30 sec. The program was repeated for 30 cycles followed
by a final extension step for 5 min. at 72°C.
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